Cargando…

Structural models of SARS-CoV-2 Omicron variant in complex with ACE2 receptor or antibodies suggest altered binding interfaces

There is enormous ongoing interest in characterizing the binding properties of the SARS-CoV-2 Omicron Variant of Concern (VOC) (B.1.1.529), which continues to spread towards potential dominance worldwide. To aid these studies, based on the wealth of available structural information about several SAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lubin, Joseph H., Markosian, Christopher, Balamurugan, D., Pasqualini, Renata, Arap, Wadih, Burley, Stephen K., Khare, Sagar D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687476/ https://www.ncbi.nlm.nih.gov/pubmed/34931193 http://dx.doi.org/10.1101/2021.12.12.472313

Ejemplares similares

Modeling of ACE2 and antibodies bound to SARS-CoV-2 provides insights into infectivity and immune evasion
por: Lubin, Joseph H., et al.
Publicado: (2023)

Genetic and Structural Analysis of SARS-CoV-2 Spike Protein for Universal Epitope Selection
por: Markosian, Christopher, et al.
Publicado: (2022)

Vascular Targeting: Recent Advances and Therapeutic Perspectives
por: Hajitou, Amin, et al.
Publicado: (2006)

Aminopeptidase N inhibitors and SARS
por: Kontoyiannis, Dimitrios P, et al.
Publicado: (2003)

Brain endothelial cell‐targeted gene therapy of neurovascular disorders
por: Marchiò, Serena, et al.
Publicado: (2016)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Bone marrow-derived CD13(+) cells sustain tumor progression: A potential non-malignant target for anticancer therapy
por: Dondossola, Eleonora, et al.
Publicado: (2014)

Ligand-directed Cancer Gene Therapy to Angiogenic Vasculature
por: Driessen, Wouter H.P., et al.
Publicado: (2009)

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection
por: Dogra, Prashant, et al.
Publicado: (2023)

A modeling-based approach to optimize COVID-19 vaccine dosing schedules for improved protection
por: Dogra, Prashant, et al.
Publicado: (2023)

Display technologies: Application for the discovery of drug and gene delivery agents()
por: Sergeeva, Anna, et al.
Publicado: (2006)

Leveraging the scientific findings to develop therapeutic strategies for dormant breast cancer cells
por: Ferrer, Alejandra, et al.
Publicado: (2022)

Molecular dynamics simulations highlight the altered binding landscape at the spike-ACE2 interface between the Delta and Omicron variants compared to the SARS-CoV-2 original strain
por: Pitsillou, Eleni, et al.
Publicado: (2022)

Does the RAAS play a role in loss of taste and smell during COVID-19 infections?
por: Luchiari, Heloise R., et al.
Publicado: (2020)

Repurposing Ferumoxytol as a Breast Cancer-Associated Macrophage Tracer with Five-Dimensional Quantitative [Fe]MRI of SPION Dynamics
por: Sillerud, Laurel O., et al.
Publicado: (2021)

Apropos of Universal Epitope Discovery for COVID-19 Vaccines: A Framework for Targeted Phage Display-Based Delivery and Integration of New Evaluation Tools
por: Markosian, Christopher, et al.
Publicado: (2021)

Structures of the Omicron Spike trimer with ACE2 and an anti-Omicron antibody
por: Yin, Wanchao, et al.
Publicado: (2022)

ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
por: Ou, Jianxia, et al.
Publicado: (2022)

Structures of ACE2–SIT1 recognized by Omicron variants of SARS-CoV-2
por: Shen, Yaping, et al.
Publicado: (2022)

SARS‐CoV‐2 omicron variant: Could it be another threat?
por: Shanmugaraj, Balamurugan, et al.
Publicado: (2022)

Nna1 gene deficiency triggers Purkinje neuron death by tubulin hyperglutamylation and ER dysfunction
por: Li, Jianxue, et al.
Publicado: (2020)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV‐2
por: Zhang, Lianghui, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2
por: Wang, Ruoke, et al.
Publicado: (2022)

Identification of Novel Immunoregulatory Molecules in Human Thymic Regulatory CD4(+)CD25(+) T Cells by Phage Display
por: Porto, Georgia, et al.
Publicado: (2011)

Poly (A)(+) Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines
por: Carraro, Dirce Maria, et al.
Publicado: (2011)

A non-ACE2-blocking neutralizing antibody against Omicron-included SARS-CoV-2 variants
por: Duan, Xiaomin, et al.
Publicado: (2022)

Mutations on RBD of SARS-CoV-2 Omicron variant result in stronger binding to human ACE2 receptor
por: Lupala, Cecylia S., et al.
Publicado: (2022)

Analyzing the interaction of human ACE2 and RBD of spike protein of SARS-CoV-2 in perspective of Omicron variant
por: Samanta, Arijit, et al.
Publicado: (2022)

An ACE2-Based Decoy Inhibitor Effectively Neutralizes SARS-CoV-2 Omicron BA.5 Variant
por: Zhang, Haoran, et al.
Publicado: (2022)

Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2
por: Golcuk, Mert, et al.
Publicado: (2022)

Correction: Poly (A)(+) Transcriptome Assessment of ERBB2-Induced Alterations in Breast Cell Lines
por: Carraro, Dirce Maria, et al.
Publicado: (2011)

Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
por: Remesh, Soumya G., et al.
Publicado: (2022)

Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
por: Remesh, Soumya G., et al.
Publicado: (2023)

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo
por: Ikemura, Nariko, et al.
Publicado: (2022)

Deciphering the Impact of Mutations on the Binding Efficacy of SARS-CoV-2 Omicron and Delta Variants With Human ACE2 Receptor
por: Khan, Alamgir, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein–ACE2 complex
por: Mannar, Dhiraj, et al.
Publicado: (2022)

Omicron: Master of immune evasion maintains robust ACE2 binding
por: Hoffmann, Markus, et al.
Publicado: (2022)

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variants of concern
por: Du, Wenjuan, et al.
Publicado: (2022)

Mutations of Omicron Variant at the Interface of the Receptor Domain Motif and Human Angiotensin-Converting Enzyme-2
por: Adhikari, Puja, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t1ddorss746md6ktfes4ut6him